Hexo (TSX:HEXO) Stock: Will This Pot Stock Surge Higher Post Earnings?

Will Hexo (TSX:HEXO) stock outperform markets in the second half of 2020?

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shares of cannabis giant Hexo (TSX:HEXO)(NYSE:HEXO) have surged higher by 26% in the last week. Hexo stock gained over 6% after it announced its Q3 results on June 12 to close trading at $1.36.

Hexo reported net revenue of $22.1 million, a sequential rise of 30% and above analyst estimates of $20.3 million. Its EBITDA loss of $4.3 million was lower than its Q2 loss of $8.5 million. However, Hexo reported a net loss of $0.07 per share, or $19.5 million in Q3, compared to a net loss of $0.04 per share, or $7.8 million in Q2. The marijuana heavyweight also missed analyst average estimate of a loss of $0.05 per share.

Hexo attributed the better-than-expected top-line growth to higher demand for its Original Stash product. Original Stash is Hexo’s low-priced value brand that was launched last year to take on sales from Canada’s thriving black market. The company’s recently launched new hash and oil extract products also contributed to strong Q3 sales.

Hexo now aims to be EBITDA positive in the first half of fiscal 2021. It is also looking to leverage its partnership with Molson Coors and expand into the hemp-derived CBD beverage market south of the border.

What next for Hexo investors?

Despite the recent upward spiral, Hexo’s stock price is trading 87% below record highs. The companies in the Canadian marijuana space continue to be impacted by structural issues. The slow rollout of retail stores in major provinces has resulted in lower-than-expected demand. This has pushed inventory levels higher, which means write-downs cannot be ruled out.

The competition from the illegal market continues to weigh on demand as does the near-term headwind of the COVID-19. Hexo is one of many pot companies that is still unprofitable and continues to burn cash. However, it might seem that the worst is over for pot stocks.

Hexo is one of Canada’s cannabis leaders. During the recent Q3 earnings call, company co-founder and CEO Sebastien St-Louis claimed that Hexo has a 30% market share in Quebec and is well poised to expand nationally and increase its footprint. Hexo management aims to the among the top two players in every market it operates.

Sebastien St-Louis is also optimistic about reaching a positive EBITDA if the retail store openings accelerates in the second half of CY 2020. The CEO stated, “Our plans to achieve adjusted EBITDA positive in the first half of fiscal 2021 or the end of the calendar year will depend on the growth of retail stores in our two largest markets, Ontario and Quebec. It’s difficult to determine the timing of new licenses for new retail stores in Ontario and the build-out of additional stores in Quebec, but we’re very encouraged by the huge progress that both our provincial partners have made.”

The Foolish takeaway

If Hexo is able to achieve profitability in the next few quarters, it will be a turning point for the company. Analysts tracking Hexo expects the company to post sales of $79.5 million in fiscal 2020. This indicates Hexo stock is trading at a price-to-sales multiple of seven, which is attractive if Hexo can expand profit margins.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »